// App-Quantinova.ai

4622 : Identification of p62/SQSTM1 as a component of non-canonical WNT VANGL2-JNK signaling in breast cancer

Researchers

Presenter

  • Jean-Paul Borg

Principal Investigators

  • Puvirajesinghe Tania

  • Francois Bertucci

  • Daniel Birnbaum

  • Ashish Jain

  • Terje Johansen

  • Pierluigi Scerbo

  • Laurent Kodjabachian

Medical Centers

  • Institut Paoli-Calmettes, Marseille, France

  • University Hospital of Tromso, Tromso, Norway

  • Institut de Biologie du Developpement de Marseille, Aix-Marseille Universite, CNRS UMR , Marseille, France.

Locations

  • France

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Polycystic kidney disease

  • Breast cancer

  • Renal disease

  • Solid malignancies

Biomarkers

  • Bone Morphogenetic Protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved